About this trial
This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Voluntarily sign the informed consent form
Disqualifiers
Patients with lung cancer, asthma, chronic obstructive pulmonary disease, cystic fibrosis, or acute respiratory distress syndrome
Women during pregnancy or breastfeeding
Patients with chronic kidney disease (GFR <60 ml/min) or liver cirrhosis
Individuals unable to cooperate in collecting exhaled breath samples
Trial design
Treatments tested in this trial
- Lipid Abnormality Mass Spectrometry Screening Model